Keywords: AMPK; AMP-activated protein kinase; ARF6; ADP-ribosylation factor 6; AKT; protein kinase B; BBB; blood brain barrier; bFGF; b-fibroblast growth factors; b-FGFR; b-fibroblast growth factors receptor; ccRCC; clear cell renal cell carcinoma; ECs; endothelial
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ABL; Absorbing Boundary Layer; SW; Spin Wave; LL; Landau-Lifshitz; PML; Perfectly Matched Layer; FDTD; Finite Difference Time Domain; GPU; Graphics Processing Unit; FD; Finite Difference; YIG; Yttrium Iron Garnet; Transmission line; Tx line; Magnetizati
Keywords: Central nervous system; Craniotomy; Crohn disease; Lymphoma; Multiple sclerosis; Natalizumab; Tsyabri; EBV; Epstein-Barr virus; FDA; Food and Drug Administration; HHV; Human herpesvirus; HIV; Human immunodeficiency virus; Ig; Immunoglobulin; LPD; Lymphopr
Keywords: AID; AutoImune Disease; CMV; Cytomegalovirus; CTCAE; Common Terminological Criteria of Adverse Events; ICU; Intensive Care Unit; IE; Infectious Event; MHD; Monoclonal Hematological Disorder; PML; Progressive Multifocal Leukoencephalopathy; SIE; Severe Inf
Keywords: Stiffness matrix method; Elastic waves; Fluid-soil coupling; Vertically transverse isotropy (VTI); PML; Foundation impedances; Discontinuity seismic source;
Keywords: Apo; apolipoprotein; BPsys; systolic blood pressure; CS; chondroitin sulfate; CVD; cardiovascular disease; DS; dermatan sulfate; EDTA; ethylene diamine tetraacetic acid; GAG; glycosaminoglycan; HS; heparan sulfate; HSBGF; heparan sulfate-binding growth fa
Keywords: Multiple sclerosis; Natalizumab; Fingolimod; Disease modifying drugs; Drug Switching; Immunomodulation; PE; primary endpoint; SE; secondary endpoint; REA; recurrent event analysis; PML; progressive multifocal leukoencephalopathy; aPBVC; annualized percent
Keywords: 2-dimensional echocardiography; 3-dimensional echocardiography; computed tomography; direct transcatheter annuloplasty; indirect transcatheter annuloplasty; mitral regurgitation; mitral stenosis; paravalvular mitral leak; transcatheter mitral intervention
Keywords: IBD; inflammatory bowel disease; MS; multiple sclerosis; PML; progressive multifocal leukoencephalopathy; RBS; rectal bleeding subscore; S1P; sphingosine-1-phosphate; TNF; tumor necrosis factor; ULN; upper limit of normal; Sphingosine-1-phosphate; Inflamm
Keywords: ADA; antidrug antibody; AGA; American Gastroenterological Association; Anti-TNF; anti-tumor necrosis factor; AZA; azathioprine; CD; Crohn disease; CTE; computed tomography enterography; EIM; extraintestinal manifestation; FDA; Food and Drug Administrati
Keywords: mitral valve; bicuspid valve; mitral leaflets; accessory scallop; human heart; connected scallops; clefts; indentations; AcS; accessory scallop; AML; anterior mitral leaflet; BMI; body mass index; PML; posterior mitral leaflet;
Keywords: ATP; adenosine triphosphate; Ca2+; Â calcium; CamK; calmodulin-dependent kinase; ChREBP; carbohydrate response element binding protein; CypD; cylophilin D; DGAT2; diacylglycerol acyltransferase 2; ER; endoplasmic reticulum; FOXO1; Forkhead box O1; G6P; gl
Keywords: Sovereign default risk; Hotz-Miller estimation; Endogenous default risk; Conditional choice probabilities; PML; GMM;
Keywords: FDTD; Graphene; Optic; PML; SBC; SPP
Keywords: ART; antiretroviral therapy; CCR; chemokine receptor; CI; confidence interval; CMV; Cytomegalovirus; CNS; central nervous system; CRP; C-reactive protein; CSF; cerebrospinal fluid; HIV; human immunodeficiency virus; HR; hazard ratio; IFN; interferon; IP;
Keywords: SASP; senescence-associated secretory phenotype; DDR; DNA-damage response; OIS; oncogene-induced senescence; ROS; reactive oxygen species; HMGB1; nuclear protein high mobility group box 1; SAHF; senescence-associated heterochromatin foci; SMS; senescence-
Keywords: AIDS; acquired immunodeficiency virus; ANI; asymptomatic neurocognitive impairment; BBB; blood brain barrier; BDNF; brain derived neurotrophic factor; cART; combination antiretroviral therapy; CDC; Centers for Disease Control and Prevention; CNS; central
Keywords: Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: postępująca wieloogniskowa leukoencefalopatia; PML; rytuksymabProgressive multifocal leukoencephalopathy; PML; Rituximab
Keywords: Bénéfice-risque; LEMP; Natalizumab; Sclérose en plaques; Sérologie JCV; Benefit-risk; PML; Natalizumab; Multiple sclerosis; JCV serology;
Keywords: Pin1; the peptidyl-prolyl cis-trans isomerase; SRC-3/AIB1; steroid receptor coactivator 3; FAK; focal adhesion kinase; Mcl-1; myeloid cell leukemia-1; p70S6K; ribosomal S6 kinase; Stat3; signal transducers and activators of transcription 3; PKB/Akt; serin
Keywords: PML; JCV; Natalizumab; Multiple sclerosis
Keywords: 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Keywords: Electromagnetic wave propagation in random media; Scattering; Maxwell’s equations; Absorber; PML
Keywords: CDR3; complementarity-determining region-3; CNS; central nervous system; CSF; cerebrospinal fluid; iATP; intracellular ATP concentration; JCV; JC virus; KRECs; K-deleting recombination excision circles; miRNA; microRNA; MRI; magnetic resonance imaging; MS
Keywords: Epstein-Barr virus; Arsenic; LMP1; PML; Latency;
Keywords: EDSS; expanded disability status scale; EQ-5D; EuroQuol questionnaire; ETDRS; early treatment diabetic retinopathy study; MRI; magnetic resonance imaging; MS; multiple sclerosis; MSVQ-7; MS-specific vision questionnaire; NARCOMS; North American Research C
Keywords: Fourier-modal method; FMM; Rigorous coupled-wave analysis; RCWA; Perfectly matched layers; PML; Computational costs; Logarithmic complexity; Aperiodic Fourier-modal method; AFMM-CFF; Alternative discretization
Keywords: BBB; blood-brain barrier; CNS; central nervous system; DMF; dimethyl fumarate; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; FDA; Food and Drug Administration; GA; glatiramer acetate; JCV; John Cunningham virus; MRI; magnetic res
Keywords: FDA; Food and Drug Administration; IFN; Interferon; JC; John Cunningham; MRI; Magnetic resonance imaging; MS; Multiple sclerosis; PML; Progressive multifocal leukoencephalopathy; Th; T helper;
Keywords: GRIP1; glucocorticoid receptor-interacting protein 1; TIF2; translation initiation factor 2; SRC; steroid receptor coactivator; NR; nuclear receptor; AD; activation domain; CBP; CREB binding protein; APL; acute promyelocytic leukemia; RAR; retinoic acid r
Keywords: Scattering; Target-strength; Littoral; Finite element; Structural-acoustics; Multi-layered sediment; PML;
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Keywords: Progressive multifocal leukoencephalopathy; PML; JCV; CD4; CD8; IFN;
Telomeric Recombination Induced by DNA Damage Results in Telomere Extension and Length Heterogeneity
Keywords: ALT; Alternative lengthening of telomeres; APBs; ALT-associated PML bodies; BIR; Break-induced replication; CO-FISH; Chromosome orientation fluorescence in situ hybridization; DDR; DNA damage response; DOX; Doxycycline; DSBs; Double-strand breaks; HR; Hom
SIPS as a model to study age-related changes in proteolysis and aggregate formation
Keywords: AGEs; advanced glycation endproducts; ALP; autophagy-lysosomal pathway; ATM; ataxia teleangiectasia mutated; BrdU; bromodeoxyuridine; DDR; DNA damage response; DOX; doxorubicin; HDFs; Human diploid fibroblasts; H2O2; hydrogen peroxide; ICAM; intercellular
Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells
Keywords: PML; Arsenic; Solubility; SUMOylation; DAXX; MDM2;
Thermal tolerance and thermal sensitivity of heart mitochondria: Mitochondrial integrity and ROS production
Keywords: HF; Heart failure; CTmax; Critical upper temperature; H2O2; Hydrogen peroxide; PMSP; State 3 respiration with pyruvate, malate and succinate; CI-IV; Complex I to IV; SP; State 3 respiration with succinate; SL; Leak respiration with succinate; PMSE; Uncoup
Mitochondria-associated membranes (MAMs): An emerging platform connecting energy and immune sensing to metabolic flexibility
Keywords: Organelle communication; Mitochondria-associated membranes; Nutrients; Microbiome; Innate immunity; Insulin sensitivity; Metabolic diseases; Ca2+; calcium; CLRs; C-type lectin receptors; CypD; cyclophilin D; DAMPs; Danger-Associated Molecular patterns; ER
PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions
Keywords: Pura (Pur-alpha); Purb; Pur-beta; Purg; Pur-gamma-A and Pur-gamma-B; AIDS; Myelodysplastic syndrome; Acute myelogenous leukemia; AML; Progressive multifocal leukoencephalopathy; PML; Polyomavirus JC; JCV; Fragile X syndrome; FXS; FMR1; Amyotrophic lateral
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
Keywords: AE; adverse event; ARR; annualized relapse rate; DMF; dimethyl fumarate; DMT; disease-modifying therapy; HR; hazard ratio; IPTW; inverse probability of treatment weight; JCV; John Cunningham virus; MS; multiple sclerosis; PML; progressive multifocal leuko
YAP promotes breast cancer metastasis by repressing growth differentiation factor-15
Keywords: ALPP; alkaline phosphatase; AREG; amphiregulin; α-SMA; alpha smooth muscle actin; BIRC5; baculoviral inhibitor of apoptosis repeat-containing 5; ChIP; chromatin immunoprecipitation; CTGF; connective tissue growth factor; DDIT4; DNA-damage inducible trans
Ampullary carcinoma-A genetic perspective
Keywords: AVC; ampulla of vater carcinoma; KRAS; Kirsten rat sarcoma viral oncogene homolog; OS; overall survival; RFS; recurrence free survival; HER2; human epidermal growth factor receptor 2; BRAF; B rapidly activated fibrosarcoma; BRCA2; breast cancer 2; TP53; t
CACUL1/CAC1 attenuates p53 activity through PML post-translational modification
Keywords: CACUL1; PML; SUMO; Ubiquitin; p53;
The human CTC1/STN1/TEN1 complex regulates telomere maintenance in ALT cancer cells
Keywords: ALT; alternative lengthening of telomeres; CST; the CTC1/STN1/TEN1 trimeric complex; APBs; ALT-associated promyelocytic leukemia bodies; PML; promyelocytic leukemia; ECTR; extrachromosomal circular telomere repeats; TC; t-circle; CC; C-circle; HDR; homolo
Asymptotically Matched Layer (AML) for transient wave propagation in a moving frame of reference
Keywords: Convected coordinates; Finite element method; Absorbing boundary; PML; Moving load; Transient wave propagation;
GATA5 SUMOylation is indispensable for zebrafish cardiac development
Keywords: WT; wild-type; UBC9; ubiquitin-conjugating enzyme E2I; SAE1/SAE2; SUMO-activating enzyme subunit 1 and 2; PML; promyelocytic leukemia protein; SENP2; sentrin-specific protease 2; SENP5; sentrin-specific protease 5; ASDs; atrial septal defects; VSDs; ventr
ReviewThe Histone Variant H3.3 in Transcriptional Regulation and Human Disease
Keywords: PTM; post-translational modification; DAXX; death domain-associated protein; UBN1; ubinuclein-1; HIRA; histone cell cycle regulation defective homolog A; ESC; embryonic stem cell; PML; promyelocytic leukemia; CHD1; chromodomain helicase DNA-binding domain
Herpesvirus DNA polymerases: Structures, functions and inhibitors
Keywords: ACV; acyclovir; CDV; cidofovir; dGTP; deoxyguanosine triphosphate; dNTP; deoxynucleotide triphosphate; E; early; EBV; Epstein-Barr virus; FOS; foscarnet; GCV; ganciclovir; gB/D; glycoprotein B/D; HCMV; human cytomegalovirus; HHV; human herpes virus; HIV;
Perfectly matched layers for convex truncated domains with discontinuous Galerkin time domain simulations
Keywords: Wave propagation; Unbounded domain; Discontinuous Galerkin; PML; Absorbing boundary condition; Absorbing layer;
The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting
Keywords: Congenital HCMV; Guinea pig CMV; Immediate-early 1; HSV-1; Innate immunity; Nuclear domain 10; PML; Daxx; Interferon; JAK-STAT;